Caitriona Ryan

, Ireland


Presentations

Persistence of Improvement in Sexual Impact Associated with Moderate-to-Severe Genital Psoriasis for up to 52 Weeks of Treatment with Ixekizumab 09 October 2019 00:00 - 00:00

Abstracts

Persistence of Improvement in Sexual Impact Associated with Moderate-to-Severe Genital Psoriasis for up to 52 Weeks of Treatment with Ixekizumab Psoriasis More